The preparation of a kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution containing ginsenoside Rg3 0.5ˆ¼10 mg/ml: add 0.1-5% of ginsenoside solution to 0.1ˆ¼30% of adjuvant A, B‘ ‘¡‘¤ at the temperature of 40ˆ¼100°C, the ratio of these two is 1:1ˆ¼300, add water after the solvent is recycled under reduced pressure； another kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution contains 0.1ˆ¼2mg/ml of 20 (R) of the ginsenoside Rg3, the preparation: add 0.1ˆ¼5% of ginsenoside solution to 20ˆ¼65% of adjuvant B‘¢‘£ at the temperature of 60ˆ¼100°C, main material to adjuvant B=1:100ˆ¼400, add water after the solvent is recycled under reduced pressure. The above 20 (R) ginsenoside Rg3 composition aqueous solution and the powder after lyophilizaton can be used to prepare injectable, oral administration and external use, and the bioactivity of these preparations is high, and with the actions of anti cancer, efficacy potentiation and toxicity attenuation effects of the combined chemical or radiation therapy of tumor, enhancement of human immune functions, improvement of human memory, anti fatigue, and detumescence, pain relieving.한종20(R)-인삼Ginsenoside Rg3 약용조합물,그원료는0.5-10밀로그람/밀로리터,그수집방법은:0.1~5%의인삼Ginsenosede 용액을 가열하여40~100℃의 0.1-30%의 원료A,B①②⑤수용액중,그들의 질량비는1:-300,감압하여 용액을 수집한후 물을 추가한다； 다른 한종원료0.1-2밀로그람/밀로리터의20/(R)-인삼Ginsenoside Rg3약용조합물,그수집방법은: 0.1~5%의인삼Ginsenosede 용액을 가열하여60~100℃의 20-65%의 원료B의 수용액중, 그들의 질량비는1:100-400,감압하여 용액을 수집한후 물을 추가한다； 20(R)-인삼Ginsenoside Rg3 약용조합물과건조후 얻는 수영성분말,그를 리용하여주사,구술과 외부 사용에 대한 제약 준비의 생물리용률이 높고,안티-종양,방사선 치료와 화학 결합의 효율성을 감쇠 시키고, 면역 공능도 제고 할수있고,피로를 감속시키고,기억력도 제고시키고,통증 완화와 상처 치유의 역할을 가집니다.
